© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Canrenoate Potassium goes by the molecular formula C22H29KO4. Chemically, it stands out as a synthetic steroid with recognized diuretic qualities, building on a spironolactone backbone. It appears most often as a solid, ranging from fine flakes to granulated powder or even crystalline pearls, displaying a pale off-white or slightly yellowish look. This compound dissolves readily in water, forming a clear, stable solution, and tends to offer a smooth, uniform distribution when added to liquid media. Its stability in aqueous solutions and safe handling at room temperature add value in medical and laboratory settings. HS Code identification typically classifies it within the section of organic chemicals, aiding clear regulatory tracking.
Solid Canrenoate Potassium shows a specific density recorded around 1.3 g/cm³. The compound’s crystalline structure underpins that stability across various temperatures, lending robustness during shipping and storage. Under standard conditions, it resists clumping and maintains integrity even in fine powder form, avoiding issues such as dust generation or static buildup. Due to its ionic nature — potassium as a stabilizing counterion — the flake or crystal form hydrates easily, seamlessly integrating into aqueous solutions. This consistency also helps dosing accuracy and ensures patient safety in therapeutic applications.
You’ll spot Canrenoate Potassium as dry, odorless flakes or crystalline powder. Handling tends to be straightforward: product pours reliably and rarely cakes. Some suppliers refine it into sterile pearls or solubilized forms for tailored requirements. In solution form, Canrenoate Potassium mixes to a particle-free, clear liquid measured in liters, which eases both large-scale hospital dosing and precise laboratory use. Granularity, whether in coarse flakes or micronized powder, often responds to intended user workflows and mixing styles.
Canrenoate Potassium draws attention for its balanced profile between therapeutic impact and chemical handling. Standard practice during production starts with raw materials that undergo thorough quality checks — from purity of the active molecule to the cleanliness of input solvents. Safety sheets advise using gloves and eye protection, pointing out dust inhalation risks on direct handling. As with most steroidal compounds, safe storage in cool, dry conditions keeps stability high and limits accidental degradation. Direct ingestion or inhalation in concentrated form can be harmful, while dilute medical formulations show strong safety when used under prescribed guidance. Proper labeling with hazard and handling codes ensures alignment with both shipping laws and medical supply chains.
With a molecular weight of about 410.6 g/mol, Canrenoate Potassium’s detailed specification data covers melting points, solubility, and pH stability. Spectroscopic analysis (such as IR or NMR) confirms structure and purity batch by batch. Quality checks at this stage remain essential: impurities impact both chemical reactivity and patient outcomes. Laboratory reports reference retention times and UV-vis absorption peaks, which support regulatory certifications and lot traceability. International trade relies on these data, citing its HS Code for customs and compliance.
Scrutinizing these physical and chemical features of Canrenoate Potassium informs pharmacists, clinicians, and manufacturers on every step — from purchasing and transport to dosing and patient care. Missteps in density measurement or mishandling the solid forms might mean inaccurate medical dosing; overlooking labeling or hazard advice can trigger supply chain setbacks and health risks. Stakeholders learn from on-the-ground experience: temperature fluctuations in storage or minute contaminant traces impact both product integrity and patient safety. Solutions? Rely on robust supplier documentation, regular staff training, and real-time verification of product authenticity and batch quality. Emphasizing this level of vigilance keeps both routine clinical practice and broader-scale pharmaceutical manufacturing running smoothly, underlining why understanding and respecting Canrenoate Potassium’s material characteristics is never a luxury.
